Fasken Martineau DuMoulin LLP advised the sole agent and sole bookrunner. On July 4, 2022, Algernon Pharmaceuticals Inc. (CNSX:AGN) announced the closing of its previously announced marketed…
Algernon Pharmaceuticals Inc.’s C$1.1 Million Public Offering
